Morphogenesis timing of genetically programmed brain malformations in relation to epilepsy.

Area of Science:

• Developmental Neuroscience
• Neuroembryology
• Pathology of Cerebral Malformations

Background:

• Cerebral malformations arise from abnormal tissue morphogenesis during development.
• Disruptions in the timing of genetic expression and neurodevelopmental processes are critical factors.
• These disruptions can be genetic or acquired in utero (e.g., ischemia, toxins).

Purpose of the Study:

• To elucidate the role of timing in the pathogenesis of cerebral malformations.
• To differentiate the mechanisms underlying various types of focal cortical dysplasia (FCD) and hemimegalencephaly (HME).
• To explore potential reasons for varying epileptogenicity in cerebral malformations.

Main Methods:

• Analysis of neurodevelopmental processes and their timing.
• Histological examination to identify cellular and architectural abnormalities.
• Comparison of pathogenetic mechanisms for FCD types 1, 3, and 2, and HME.

Main Results:

• FCD types 1 and 3 may represent arrested maturation of neocortical architecture.
• FCD type 2 and HME likely result from somatic mutations with timing-dependent effects on neuronal populations.
• Early mutations lead to HME, while late mutations result in FCD2.

Conclusions:

• Timing of developmental events is paramount in understanding cerebral malformations.
• Somatic mutations occurring at different stages of neuroepithelial mitosis can explain FCD2 and HME.
• The epileptogenicity of cerebral malformations may relate to synaptic circuitry differences.